Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Clinical trial NCT05738057 · UNKNOWN
Trial details
- NCT number
- NCT05738057
- Sponsor
- Hua Li
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-30
- Primary completion
- 2025-03-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.